Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial
Public ClinicalTrials.gov record NCT07723235. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Health Engagement for Rural Ohio Cancer Survivors (HERO-C)
Study identification
- NCT ID
- NCT07723235
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Ohio State University Comprehensive Cancer Center
- Other
- Enrollment
- 90 participants
Conditions and interventions
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Endometrial Carcinoma
- Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
- Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
- Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Interventions
- Aerobic Exercise Other
- Biospecimen Collection Procedure
- Dietary Intervention Other
- Discussion Other
- Goal Setting Other
- Internet-Based Intervention Other
- Medical Device Usage and Evaluation Other
- Questionnaire Administration Other
- Resistance Training Other
- Smartphone Application-based Intervention Behavioral
- Supportive Care Other
- Tailored Intervention Procedure
Other · Procedure · Behavioral
Eligibility (public fields only)
- Age range
- 40 Years to 69 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 9, 2026
- Primary completion
- Dec 30, 2027
- Completion
- Dec 30, 2027
- Last update posted
- Jul 22, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07723235, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07723235 live on ClinicalTrials.gov.